189 related articles for article (PubMed ID: 20610727)
1. Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.
Moulton EA; Bertram P; Chen N; Buller RM; Atkinson JP
J Virol; 2010 Sep; 84(18):9128-39. PubMed ID: 20610727
[TBL] [Abstract][Full Text] [Related]
2. Surviving mousepox infection requires the complement system.
Moulton EA; Atkinson JP; Buller RM
PLoS Pathog; 2008 Dec; 4(12):e1000249. PubMed ID: 19112490
[TBL] [Abstract][Full Text] [Related]
3. EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence.
van Buuren N; Burles K; Schriewer J; Mehta N; Parker S; Buller RM; Barry M
PLoS Pathog; 2014 Aug; 10(8):e1004326. PubMed ID: 25122471
[TBL] [Abstract][Full Text] [Related]
4. The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.
Johnson JB; Grant K; Parks GD
J Virol; 2009 Aug; 83(15):7602-11. PubMed ID: 19457998
[TBL] [Abstract][Full Text] [Related]
5. Primary naive and interleukin-2-activated natural killer cells do not support efficient ectromelia virus replication.
Parker AK; Yokoyama WM; Corbett JA; Chen N; Buller RML
J Gen Virol; 2008 Mar; 89(Pt 3):751-759. PubMed ID: 18272767
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.
Avirutnan P; Fuchs A; Hauhart RE; Somnuke P; Youn S; Diamond MS; Atkinson JP
J Exp Med; 2010 Apr; 207(4):793-806. PubMed ID: 20308361
[TBL] [Abstract][Full Text] [Related]
7. A Factor I-Like Activity Associated with Chikungunya Virus Contributes to Its Resistance to the Human Complement System.
Nag J; Mukesh RK; Suma SM; Kunnakkadan U; Kumar NA; Johnson JB
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941783
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion.
Biswas M; Johnson JB; Kumar SR; Parks GD; Elankumarana S
J Virol; 2012 Dec; 86(23):12708-16. PubMed ID: 22973037
[TBL] [Abstract][Full Text] [Related]
9. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763
[TBL] [Abstract][Full Text] [Related]
10. The Pathogenesis and Immunobiology of Mousepox.
Sigal LJ
Adv Immunol; 2016; 129():251-76. PubMed ID: 26791861
[TBL] [Abstract][Full Text] [Related]
11. Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.
Mark L; Proctor DG; Blackbourn DJ; Blom AM; Spiller OB
Immunology; 2008 Feb; 123(2):228-38. PubMed ID: 17764451
[TBL] [Abstract][Full Text] [Related]
12. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
13. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
14. The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.
Xu RH; Cohen M; Tang Y; Lazear E; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
J Exp Med; 2008 Apr; 205(4):981-92. PubMed ID: 18391063
[TBL] [Abstract][Full Text] [Related]
15. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.
Bernet J; Ahmad M; Mullick J; Panse Y; Singh AK; Parab PB; Sahu A
Vaccine; 2011 Oct; 29(43):7435-43. PubMed ID: 21803094
[TBL] [Abstract][Full Text] [Related]
16. Human Adenovirus Serotype 5 Is Sensitive to IgM-Independent Neutralization In Vitro and In Vivo.
Doszpoly A; de la Cuesta F; Lopez-Gordo E; Bénézech C; Nicklin SA; Baker AH
Viruses; 2019 Jul; 11(7):. PubMed ID: 31284434
[TBL] [Abstract][Full Text] [Related]
17. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
Li Y; Parks GD
Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
[TBL] [Abstract][Full Text] [Related]
18. N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.
Gratz MS; Suezer Y; Kremer M; Volz A; Majzoub M; Hanschmann KM; Kalinke U; Schwantes A; Sutter G
J Virol; 2011 Apr; 85(7):3557-69. PubMed ID: 21270149
[TBL] [Abstract][Full Text] [Related]
19. A homolog of the variola virus B22 membrane protein contributes to ectromelia virus pathogenicity in the mouse footpad model.
Reynolds SE; Earl PL; Minai M; Moore I; Moss B
Virology; 2017 Jan; 501():107-114. PubMed ID: 27898336
[TBL] [Abstract][Full Text] [Related]
20. Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver.
Xu RH; Rubio D; Roscoe F; Krouse TE; Truckenmiller ME; Norbury CC; Hudson PN; Damon IK; Alcamí A; Sigal LJ
PLoS Pathog; 2012 Jan; 8(1):e1002475. PubMed ID: 22241999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
